Related Experiment Video

Updated: Aug 14, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 23, 2010

Constitutive activation of the RON gene promotes invasive growth but not transformation

M M Santoro1, C Collesi, S Grisendi

  • 1Institute for Cancer Research, University of Turin Medical School, Italy.

Insights

Researchers investigated the oncogenic potential of the RON receptor tyrosine kinase. Constitutively active Tpr-Ron induced cell motility and invasion but not transformation, suggesting a motile-invasive rather than transformed phenotype.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The MET, RON, and SEA gene family encodes tyrosine kinase receptors involved in cell growth, motility, and tubule formation.
  • While oncogenic forms of MET and SEA exist, no transforming variants of RON have been identified.

Purpose of the Study:

  • To investigate the transforming potential of a constitutively active chimeric RON kinase (Tpr-Ron).
  • To compare the transforming abilities of Tpr-Ron with Tpr-Met and Tpr-Sea.
  • To elucidate the functional differences underlying the transforming capacities of these kinases.

Main Methods:

  • Construction of chimeric Tpr-Ron and Tpr-Sea fusion proteins.
  • Assessment of NIH 3T3 cell transformation.
  • Subdomain swapping experiments to analyze kinase function.
  • Kinetic analysis and MAP kinase signaling cascade activation studies.
  • Evaluation of cell behavior in tridimensional collagen gels.

Main Results:

  • Constitutive activation of RON and SEA kinases was achieved via Tpr fusion.
  • Tpr-Ron did not transform NIH 3T3 cells, unlike Tpr-Sea and Tpr-Met.
  • Tpr-Ron exhibited lower catalytic efficiency and MAP kinase activation compared to Tpr-Met.
  • Constitutive RON activation promoted cell dissociation, motility, invasion, and formation of unbranched tubules.

Conclusions:

  • RON, when constitutively activated, primarily elicits a motile-invasive phenotype rather than a transformed phenotype.
  • Functional differences in tyrosine kinase domains dictate the distinct cellular responses to MET, RON, and SEA activation.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...